Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 12/20 | 0.54 |
| ▸ | ADRB3 | P13945 | 12/20 | 0.54 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6538732 | 0.96 | ADRB1 (0.50) | ADRB1ADRB3ADRB2NPC1RAB9A | |
| SCHEMBL6538663 | 0.94 | ADRB1 (0.48) | ADRB1ADRB3ADRB2NPC1RAB9A | |
| SCHEMBL6540060 | 0.94 | ADRB1 (0.48) | ADRB1ADRB3ADRB2NPC1RAB9A | |
| SCHEMBL6538889 | 0.93 | ADRB1 (0.49) | ADRB1ADRB3ADRB2KMT2AMEN1 | |
| SCHEMBL6539381 | 0.93 | ADRB1 (0.54) | ADRB1ADRB3ADRB2NPC1RAB9A | |
| SCHEMBL6538485 | 0.92 | ADRB1 (0.47) | ADRB1ADRB3ADRB2NPC1RAB9A | |
| SCHEMBL6539155 | 0.91 | RAB9A (0.54) | ADRB1ADRB3ADRB2NPC1RAB9A | |
| SCHEMBL6539792 | 0.91 | ADRB1 (0.53) | ADRB1ADRB3ADRB2NPC1RAB9A | |
| SCHEMBL6539512 | 0.91 | ADRB1 (0.52) | ADRB1ADRB3ADRB2NPC1RAB9A | |
| SCHEMBL6539030 | 0.91 | KDM4E (0.47) | ADRB1ADRB3ADRB2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6826033-B2 | BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-11-30 | — | — | US | disclosed |
| US-20040037022-A1 | Aminoalcohol derivatives | ASTELLAS PHARMA INC. (JP) | 2004-02-26 | — | — | US | disclosed |
| WO-2002024635-A2 | AMINOALCOHOL DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-03-28 | — | — | WO | disclosed |